For: | Gu JN, Yao S, Cao YH, Deng SH, Mao FW, Jiang HY, He YT, Li XY, Ke SQ, Li HL, Li H, Liu XH, Liu HL, Wang JL, Wu K, Liu L, Cai KL. Novel parameter based on lipid indicators ratio improves prognostic value of plasma lipid levels in resectable colorectal cancer patients. World J Gastrointest Surg 2021; 13(7): 689-701 [PMID: 34354802 DOI: 10.4240/wjgs.v13.i7.689] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i7/689.htm |
Number | Citing Articles |
1 |
Meijuan Tan, Shijie Yang, Xiequn Xu. High-density lipoprotein cholesterol and carcinogenesis. Trends in Endocrinology & Metabolism 2023; 34(5): 303 doi: 10.1016/j.tem.2023.02.009
|
2 |
Jin-Hua Tao, Xiao-Tong Wang, Wei Yuan, Jia-Nan Chen, Zhi-Jie Wang, Yun-Bin Ma, Fu-Qiang Zhao, Liu-Yuan Zhang, Jie Ma, Qian Liu. Reduced serum high-density lipoprotein cholesterol levels and aberrantly expressed cholesterol metabolism genes in colorectal cancer. World Journal of Clinical Cases 2022; 10(14): 4446-4459 doi: 10.12998/wjcc.v10.i14.4446
|
3 |
Hailun Xie, Lishuang Wei, Qiwen Wang, Shuangyi Tang, Jialiang Gan. Apolipoprotein A-I levels in the survival of patients with colorectal cancer: a retrospective study. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1318416
|